Skip to main content
OpenTrials
Completed

NCT Number: NCT06263140

Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

Serum vitamin D levels in drug-induced non-immediate reactions

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stevens-Johnson Syndrome Avitaminosis Chemically-Induced Disorders Deficiency Diseases Dermatitis Drug Eruptions Drug Hypersensitivity Drug Hypersensitivity Syndrome Drug Reaction With Eosinophilia and Systemic Symptom Drug-Induced Rash Drug-Related Side Effects and Adverse Reactions Erythema Erythema Multiforme Hypersensitivity Hypersensitivity, Delayed Immune System Diseases Maculopapular Exanthem Malnutrition Mouth Diseases Nutrition Disorders Nutritional and Metabolic Diseases Skin Diseases Skin Diseases, Vesiculobullous Skin and Connective Tissue Diseases Stomatitis Stomatognathic Diseases Vitamin D Deficiency

Age range

15 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine, Chulalongkorn University

Bangkok, 10330, Thailand

About this study

The study of serum vitamin D levels in patients presented with drug-induced non-immediate cutaneous adverse reactions compared to those in drug-tolerant control subjects

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with SJS/TEN, DRESS, AGEP, MPE, or FDE as mentioned above

Exclusion criteria

  • Reactions from drugs with known strong genetic predispositions (allopurinol, carbamazepine, abacavir)
  • Receiving vitamin D supplement

Treatment and study plan

Primary outcomes

  1. Serum vitamin D levels

    Time frame: At baseline

    Serum vitamin D levels at baseline

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Official study title

A Study of Vitamin D Levels in Patients With Non-immediate Drug Hypersensitivity, Case-control Study

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 16, 2024
Registry last updated
Feb 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.